Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by brax21on Jan 24, 2008 2:32am
428 Views
Post# 14252680

RE: Manipulation?

RE: Manipulation?Hey Cardu It appears to be manipulated to some degree but likely for the people long on this stock it has been a very painful journey of ups and downs with too many downs lately and it's to the point nobody cares too much about the prices currently. If you have never been in the stock before I think it's a very decent entry price. I've been in this stock since around 2000 and have had multiple entry points at various prices. I still believe they have the "goods", their IP is getting stronger, making gains in many areas but it is just going at a snails pace. Unfortunately I believe people are tired of hearing Brad repeat alot of the same stuff year after year and disappointed with all the phase 1 trials, etc. I do believe the product will get to market one way or another. I usually say patience is key, but I never thought I would need to be patient for this long of a stretch. Hang in there, I believe there should be a light at the end of this tunnel eventually brax21
Bullboard Posts